Health & Science

Home Health & Science

MAHA Year One: How Trump & RFK Jr. Are Rebuilding American Health

1
By Gage Skidmore from Surprise, AZ, United States of America - Robert F. Kennedy, Jr., CC BY-SA 2.0,

For decades, Americans were told a story about their health that no longer matched reality. We were assured that food was safe, that regulators were vigilant, that medical advice was insulated from politics and profit, and that rising chronic disease was an unfortunate but unavoidable byproduct of modern life. Meanwhile, the health of the nation deteriorated in plain sight. Obesity climbed year after year. Childhood chronic disease became common rather than exceptional. Autism rates surged. Cancer diagnoses among children rose. By the time President Trump returned to office, 76.4% of Americans were living with at least one chronic disease. Eight out of 10 children could not qualify for military service. What should have been treated as a civilizational emergency was instead normalized, until that long-running failure of honesty and accountability culminated during the COVID-19 pandemic, when public health leaders abandoned transparency, misled the public, and, under Dr. Fauci’s direction, shattered trust in medical professionals and the institutions meant to serve them.

The collapse of trust that followed COVID did not occur in a vacuum. It was the culmination of years of regulatory capture, scientific arrogance, and a public health establishment that confused authority with truth. Americans were ordered, not persuaded. Dissent was pathologized. Data was selectively presented. Vaccine policy was enforced through mandate rather than transparency. Dr. Fauci became the symbol of an anti-science regime that claimed infallibility while revising its claims in real time. When institutions insist on obedience while refusing accountability, trust does not merely erode; it implodes.

It is against this backdrop that the Make America Healthy Again initiative must be understood. MAHA is not a branding exercise or a partisan slogan. It is a course correction. President Trump’s decision to place Robert F. Kennedy Jr. at the helm of HHS was not an appeal to nostalgia or name recognition. It was an explicit rejection of the managerial consensus that presided over the chronic disease explosion. The mandate was simple and radical: identify root causes, dismantle regulatory capture, and tell the truth even when it disrupts powerful interests.

Skeptics ask whether one year can matter. The answer depends on what one expects a first year to do. MAHA was never going to reverse decades of metabolic, environmental, and institutional decay overnight. Its purpose was to reorient the system, establish credibility, and force long-delayed questions back into the open. By that standard, the first year has been historic.

Start with the scope of institutional change. President Trump signed an executive order establishing the MAHA Commission, chaired by Secretary Kennedy, with a singular focus on chronic disease. For the first time in generations, chronic illness was treated not as an actuarial inevitability but as a policy failure demanding investigation. This alone marked a break with orthodoxy. Under previous administrations, chronic disease spending rose to $1.3T annually while prevention remained an afterthought. When Kennedy notes that the federal government once spent essentially nothing on chronic disease, he is not making a rhetorical point. He is diagnosing a structural blind spot.

The results are already visible. Thirty-seven states have enacted legislation advancing MAHA-aligned reforms. Nearly 100 MAHA-related bills have passed nationwide. Eighteen states secured SNAP waivers to restrict taxpayer-funded junk food purchases that directly fuel obesity and diabetes. These are not symbolic victories. They are structural incentives aligned with public health rather than industry convenience.

Food policy has been the most visible arena of reform, and for good reason. The American diet did not become toxic by accident. It was engineered through regulatory loopholes that allowed synthetic additives to enter the food supply under the GRAS standard with minimal oversight. MAHA moved quickly to overhaul this system. Agreements now cover roughly 40% of the food industry, committing to remove petroleum-based synthetic dyes. The dairy industry has pledged to eliminate artificial dyes from ice cream by 2028. These changes matter because they reset norms. Once voluntary reform becomes expected, resistance collapses.

The same logic applies to infant health. Operation Stork Speed was launched to expand access to safe and nutritious infant formula while removing heavy metals that had no business entering baby food in the first place. For parents who watched institutions minimize legitimate safety concerns during COVID, this shift toward precaution and transparency has been decisive in rebuilding trust.

Critics often ask whether MAHA is anti-science. The premise is backward. MAHA is anti-dogma. It insists that science earns authority through openness, replication, and humility. This is why vaccine policy has been reframed around informed consent and gold standard trials rather than mandates. Honesty about uncertainty is not weakness. It is the precondition of credibility. Public trust returns when institutions stop pretending to be omniscient.

This emphasis on trust extends beyond food and vaccines. HHS issued guidance restoring biological truth, recognizing that there are two sexes, male and female. This was not culture war theater. Medicine depends on biological reality. When institutions deny observable facts for ideological reasons, patients notice. Restoring clarity restores confidence.

MAHA’s critics also underestimate the importance of state-level experimentation. Utah’s decision to ban added fluoride in public drinking water did not impose a national mandate. It reopened a conversation that had been closed by bureaucratic inertia. Communities are once again allowed to weigh risks and benefits rather than defer to outdated consensus.

Health care delivery itself has not been ignored. Prior authorization has long functioned as a hidden tax on patients and physicians, delaying care while enriching intermediaries. Secretary Kennedy and CMS Administrator Oz secured industry commitments to streamline this process across health plans. Less paperwork means faster treatment and lower burnout. These are the reforms patients feel immediately.

Drug pricing has followed the same philosophy. President Trump’s most favored nation order is being rapidly implemented to align U.S. prescription drug prices with those paid abroad. This is not price control masquerading as populism. It is a refusal to subsidize global markets at the expense of American patients. Lower prices are a public health intervention.

Physical health has returned to the cultural mainstream as well. The Pete and Bobby Challenge, launched by Secretary Kennedy alongside Defense Secretary Hegseth, did something that countless white papers failed to do. It made fitness visible again. A nation where most children cannot meet basic physical standards is not merely unhealthy. It is vulnerable.

The MAHA Commission’s release of the Make Our Children Healthy Again strategy, outlining more than 120 initiatives, signaled that childhood chronic disease is no longer being treated as a mystery or a taboo. New data linking rising thyroid and kidney cancers among children demands answers. Autism rates demand answers. MAHA has made clear that asking these questions is not forbidden. It is required.

Perhaps the most underestimated achievement of the first year is cultural rather than regulatory. Trust is returning because institutions are speaking plainly. The public understands that special interests once thrived behind closed doors. They know they were sold better cigarettes and sugar smacks with a health halo. What they demanded in 2024 was not perfection. It was honesty.

President Trump and Secretary Kennedy have delivered the first credible attempt in decades to dismantle the alliance between bureaucratic power and corporate profit that hollowed out public health. The appointments at NIH, FDA, and CMS reflect this shift. These are not partisan enforcers. They are reformers tasked with ending capture and restoring the mission.

No serious observer should claim that the work is finished. Chronic disease did not emerge in one year, and it will not be eliminated in one term. But trajectories matter. Incentives matter. Trust matters most of all. After years in which Americans were told to comply and not question, MAHA has reopened the social contract between the public and medicine.

Public health cannot function without consent. Consent requires trust. Trust requires truth. That is the chain MAHA is rebuilding. It is why the first year matters. Not because every problem has been solved, but because the system has finally been pointed in the right direction.

If you enjoy my work, please subscribe: https://x.com/amuse.

Sponsored by the John Milton Freedom Foundation, a nonprofit dedicated to helping independent journalists overcome formidable challenges in today’s media landscape and bring crucial stories to you.

Trump Aide Faints On Stage During Republican Gala

1
Photo via Pixabay images

An adviser to President-elect Trump’s campaign, Alex Bruesewitz, passed out and collapsed as he was speaking onstage during a New York Young Republican Club gala Sunday night.

Alex Bruesewitz, 27, was introducing incoming White House senior aide Dan Scavino inside a venue in Manhattan when he began stumbling over his words and fainted, video on social media shows.

Watch:

Several people quickly rushed to help after his collapse. It was not immediately clear what caused him to faint.

“I talked to our friend Alex Bruesewitz and you know what he said to me? He goes ‘Did I at least look cool?’ I said Alex, you used gravity like I’ve seen nobody use gravity before in their lives,” Kassam said. “But he’s recuperating back there, so give him a big cheer so he’ll hear you.”

Trump also said following the collapse that he believes Bruesewitz will be fine, according to the New York Post.

“I know that Alex is going to be fine because he’s a tough son of a gun,” Trump said. “There’s no doubt about that. So I want to say hello to Alex, because he’s a very special guy.”

Bruesewitz is the CEO of consultancy firm X Strategies LLC, which states its mission to help elect “America First” candidates. Its website says he is “a prominent political consultant and strategist known for his unwavering support of President Donald Trump and the America First agenda.”

Before his collapse, Bruesewitz commended the New York Republican Club for backing Trump’s campaign. He also gave shout-outs to several supporters of the incoming president who were at the event, including former Florida congressman Matt Gaetz, who recently resigned from his U.S. House seat.

Sen. Mike Lee Says Most Republicans Don’t Know McConnell’s Condition

Gage Skidmore from Surprise, AZ, United States of America, CC BY-SA 2.0 , via Wikimedia Commons

WASHINGTON — Sen. Mike Lee (R-Utah) says most Republican senators have little or no firsthand knowledge of Sen. Mitch McConnell’s medical condition, underscoring the uncertainty surrounding the Kentucky Republican as he remains hospitalized weeks after a serious medical emergency.

Lee made the remarks when asked about McConnell’s prolonged absence from the Senate, saying rank-and-file lawmakers have received few details beyond the limited public statements released by McConnell’s office.

‘Most Of Us Don’t Know’

Lee acknowledged that speculation has grown because so little official information has been released.

His comments contrast with earlier remarks from Senate Majority Leader John Thune, who previously said McConnell “sounded good” during a recent conversation. Lee indicated that most senators have not received similar updates and remain largely in the dark about their colleague’s condition.

Office Continues To Release Limited Information

McConnell’s office has consistently maintained that the 84-year-old senator is recovering and remains engaged with Senate business.

In its latest public statement, spokesman David Popp said McConnell “continues to improve” and is working with staff on Kentucky and Senate matters while Congress is in recess. The office has not disclosed his diagnosis, prognosis, or expected discharge date.

Medical Emergency Prompted Questions

McConnell has not appeared publicly since June 14, when emergency responders were dispatched to his Washington residence.

Emergency dispatch audio reviewed by multiple news organizations described an unconscious patient and referenced CPR in progress. McConnell’s office has not confirmed the specific medical event that led to his hospitalization.

The absence of detailed updates has fueled intense online speculation, including unverified claims promoted by White House confidant Laura Loomer. McConnell’s office has offered no support for those assertions, saying only that the senator continues to improve.

Questions Persist As Senate Recess Continues

The Senate remains in recess until later this month, giving McConnell additional time to recover before lawmakers return to Washington.

Whether he will be able to resume his duties when the Senate reconvenes remains unclear. McConnell previously announced he will not seek reelection and plans to retire when his current term expires in January 2027.

For now, Lee’s comments highlight what many senators have acknowledged privately: beyond the brief statements released by McConnell’s aides, even many of his Republican colleagues say they know little about his current condition.

READ NEXT: McConnell’s Neighbor Breaks The Silence

Tulsi Gabbard Shares Hopeful Update on Husband’s Rare Cancer Battle

Tulsi Gabbard via Gage Skidmore Flickr

Former Director of National Intelligence Tulsi Gabbard shared an emotional but hopeful update on her husband’s battle with an extraordinarily rare form of bone cancer, revealing that doctors believe they successfully removed all cancerous tissue during surgery.

In a three-minute video posted to X, Gabbard opened up about the grueling operation and difficult recovery her husband, Abraham Williams, has endured since being diagnosed with sacral chordoma earlier this year.

“A few weeks after the surgery was done, the pathologist and the doctors said that they are confident that they were able to cut out all of the cancerous bone and tissue,” Gabbard said, according to Fox News.

Nearly three months after the operation, Williams is now participating in what Gabbard described as a “very rigorous physical therapy program.”

“He gets frustrated a lot because he wants to be able to make progress faster, and sometimes he’s pushed a little bit too far, but overall, Abraham is progressing very well,” she said.

Still, Gabbard cautioned that the couple’s ordeal is far from finished.

“The reality is that the battle isn’t over yet,” she said.

Williams will require frequent MRI scans to monitor whether the cancer returns in the same location or spreads elsewhere.

Sacral chordoma is a slow-growing cancer that forms near the base of the spine. According to the National Cancer Institute, approximately one in every million people worldwide is diagnosed with chordoma each year. Surgery is the preferred treatment when possible, but removing the entire tumor can be difficult because of its proximity to nerves, blood vessels and other critical tissue.

Gabbard said Williams was given a choice between radiation and an invasive operation requiring surgeons to remove part of his sacrum and tailbone. The couple opted for surgery.

The nearly eight-hour procedure was successful, but the immediate aftermath was harrowing.

As Williams emerged from heavy anesthesia, his body reacted severely to the drugs. Gabbard recalled that he repeatedly insisted on trying to walk—with the assistance of nurses—even as he became sick.

“He would take a few steps. He would throw up as he was trying to walk around, but he kept going,” she said.

Williams also declined narcotic pain medication, forcing him to push through the intense postoperative pain with other forms of treatment, Gabbard said.

The diagnosis prompted Gabbard to resign from President Donald Trump’s Cabinet in May so she could support her husband throughout his treatment. Her departure became effective June 30.

“At this time, I must step away from public service to be by his side and fully support him through this battle,” Gabbard wrote in her resignation letter.

In Thursday’s video, Gabbard thanked God, Williams’ medical team and the countless people who sent prayers and well wishes during the family’s ordeal.

“We are so grateful to God for His unconditional love, for being our shelter, for being our peace and our strength,” she said.

The deeply personal message ended with Williams stepping into view and wrapping his wife in a tight embrace.

“Love you, darlin’,” he told her.

“I love you,” Gabbard replied.

White House Addresses Trump Health After Viral Photos Spark Speculation

By The White House - https://www.flickr.com/photos/202101414@N05/54581054338/, Public Domain,

White House press secretary Karoline Leavitt addressed concerns over President Donald Trump’s health during a briefing on Thursday after photographs of his hand appearing bruised and his ankles appearing swollen went viral.

“I know that many in the media have been speculating about bruising on the president’s hand, and also swelling in the president’s legs. So in the effort of transparency, the president wanted me to share a note from his physician with all of you today,” began Leavitt before reading from the note:

In recent weeks, President Trump noted mild swelling in his lower legs. In keeping with routine medical care and out of an abundance of caution, this concern was thoroughly evaluated by the White House Medical Unit. The president underwent a comprehensive examination, including diagnostic vascular studies. Bilateral lower extremity venous Doppler ultrasounds were performed and revealed chronic venous insufficiency, a benign and common condition, particularly in individuals over the age of 70.

Importantly, there was no evidence of deep vein thrombosis or arterial disease. Laboratory testing included a complete blood count, comprehensive metabolic panel, coagulation profile, D-dimer, B-type, natriotic, peptide, and cardiac biomarkers. All results were within normal limits. An echocardiogram was also performed, and confirmed normal cardiac structure and function. No signs of heart failure, renal impairment, or systemic illness were identified.

Additionally, recent photos of the president have shown minor bruising on the back of his hand. This is consistent with minor soft tissue irritation from frequent handshaking, and the use of aspirin, which is taken as part of a standard cardiovascular prevention regimen. This is a well-known and benign side effect of aspirin therapy, and the president remains in excellent health.

“Which I think all of you witness on a daily basis here,” added Leavitt. “So the president wanted me to share that note with all of you. I’m happy to take further questions on it. We will provide the memorandum from the president’s physician to all of you, as we always do.

Watch:

Biden Cancer Diagnosis Spurs White House Coverup Accusations

Photo via Gage Skidmore Flickr

The news of former President Joe Biden’s cancer diagnosis has sent shockwaves across America.

Biden’s team announced Sunday that he’d been diagnosed with an aggressive form of prostate cancer that had already metastasized to the bone, adding his family would examine suitable treatment for the “management” of the disease.

The shocking news comes amid heightened scrutiny surrounding the Bidens potential coverup of former President Biden’s mental and physical decline while in office.

On Monday, Rep. Ronny Jackson (R-TX) accused the Biden White House of a “political cover up” and lashed out at Biden’s then-White House doctor, though not by name, and accused the physician of having failed to deliver “world class care” to Biden and engaging in a “cover up.”

President Donald Trump posted a message to his Truth Social app on Sunday from himself and First Lady Melania Trump expressing their sympathy and well-wishes for Biden, after it was announced that the former president is battling very serious prostate cancer.

Trump Jr. likewise initially offered an expression of sympathy, by way of reposting a message on his account at X.

Sharing a screenshot that included the message “Politics aside, we wish [President Biden] a speedy recover,” Trump Jr. commented “Agreed 100%.”

In another post three hours later which also included a screenshot, Trump Jr. had a more critical take on the tragic news.

His screenshot showed a message on the nature of Biden’s particular cancer, and calling into question the timeline of when Democrats, or at least the White House, knew about it.

“What I want to know is how did Dr. Jill Biden miss stage five metastatic cancer or is this yet another coverup???” he said, with a sarcastic jab at former First Lady Jill Biden.

The hosts of Fox & Friends were in disbelief Monday morning at Joe Biden’s advanced cancer diagnosis despite the “fantastic medical care” that he receives as a former president.

“These are the types of things you look for when you get older,” Kilmeade added. “And very curious to see and somewhat discouraging to think someone could have this type of medical attention and have this get to this point.”

Co-host Charles Hurt added: “Especially because it’s a fairly advanced form so much so that it has metastasized to a bone. And you would think that would give you a lot more time to catch it.”

Later in the show, the curvy couch welcomed Fox News medical expert Dr. Marc Siegel, who echoed their surprise.

“Really, really surprising that it’s this advanced at the time of diagnosis,” he said. “Now, you can miss prostate cancer but most of the time regular screening picks it up. A sitting president I would expect to have advanced screening should not be subject to debate what kind of screening.”

Minnesota Republicans Propose Bill Classifying “Trump Derangement Syndrome” as Mental Illness

Gage Skidmore from Surprise, AZ, United States of America, CC BY-SA 2.0 , via Wikimedia Commons

Minnesota Senate Republicans have introduced a bill to define “Trump Derangement Syndrome” (TDS) as a form of mental illness. Senate Bill 2589, which is set to be formally introduced and read on March 17, 2025, igniting significant debate due to the novelty of a politically charged term in the medical lexicon.

The bill, sponsored by Republican State Senators Eric Lucero, Steve Drazkowski, Nathan Wesenberg, Justin Eichorn, and Glenn Gruenhagen, seeks to amend the state’s definition of mental illness by adding a specific reference to TDS. According to the text of the bill, mental illness would include “Trump Derangement Syndrome” or an organic disorder of the brain that significantly impairs an individual’s ability to function in daily life.

The bill describes TDS as “the acute onset of paranoia in otherwise normal persons that is in reaction to the policies and presidencies of President Donald J. Trump.” According to the proposal, individuals affected by TDS exhibit symptoms of paranoia and an inability to separate legitimate political disagreements from perceived personal or psychological pathology in Trump’s behavior.

The bill further characterizes TDS as leading to “Trump-induced general hysteria,” where individuals may struggle to distinguish between policy differences and a supposed mental condition in the former president’s actions. These symptoms, the bill argues, can severely impair personal relationships, work, and other aspects of daily living.

The bill has already been logged into the Minnesota legislature’s official website, but it is set to undergo formal introduction on March 17, 2025. Its introduction has garnered widespread attention, with reactions split along party lines.

Supporters of the bill argue that it is a legitimate attempt to address a condition that they believe affects a significant portion of the population, particularly those who strongly opposed former President Trump. By naming and defining TDS, they argue, the bill opens a discussion about how political figures can profoundly affect the psychological well-being of individuals, especially during times of heightened political polarization.

Article Published With The Permission of American Liberty News

Vanessa Trump Announces Cancer Diagnosis

The White House, Public domain, via Wikimedia Commons

Former Trump family member Vanessa Trump revealed Wednesday that she has been diagnosed with breast cancer, prompting an outpouring of support from relatives, friends, and supporters connected to President Donald Trump’s extended family circle.

The 48-year-old former model and television personality shared the news in an emotional Instagram statement, describing the diagnosis as an unexpected challenge while emphasizing that she remains optimistic.

“I’ve recently been diagnosed with breast cancer,” Vanessa wrote. “While this isn’t news anyone expects, I’m working closely with my medical team on a treatment plan.”

Vanessa also revealed that doctors performed a procedure earlier this week, though she did not provide additional details regarding the nature of the procedure or the stage of her diagnosis. She said she is relying heavily on her family and close loved ones as she begins treatment.

“I am staying focused and hopeful while surrounded by the love and support of my family, my kids, and those closest to me,” she wrote.

Vanessa concluded the statement by thanking supporters for their encouragement and asking for privacy while she focuses on recovery.

The announcement quickly drew public reactions from members of the Trump family.

President Trump’s daughter, Ivanka Trump, posted a heartfelt response beneath Vanessa’s announcement.

“Praying for your continued strength and a swift recovery. Love you mama,” Ivanka wrote.

Vanessa’s daughter, Kai Trump, also shared an emotional message, calling her mother “the strongest person I know” in a social media tribute that resonated with supporters.

Additional support reportedly came through social media engagement from other members of the Trump family as Vanessa’s announcement spread online.

Vanessa was married to Donald Trump Jr. for more than a decade before the pair divorced in 2018. The former couple share five children together and have largely maintained a cooperative relationship centered around family matters.

In recent years, Vanessa has kept a lower public profile compared to many members of the Trump family. However, she returned to headlines after legendary golfer Tiger Woods publicly confirmed their relationship in 2025. The two have since been seen together at family events and golf-related appearances.

Her diagnosis sparked an immediate wave of support online, with many supporters offering prayers and well wishes as she begins what could be a difficult health battle.

Justice Department Opens Investigation Into Former Gov. Andrew Cuomo

Photos from the opening of the new Delta Air Lines terminal in LaGuardia Airport in Queens, NY, on Tuesday, Oct. 29, 2019. (Chris Rank for Rank Studios) (Photos from the opening of the new Delta Air Lines terminal in LaGuardia Airport in Queens, NY, o

The U.S. Department of Justice has opened a criminal investigation into former New York Gov. Andrew Cuomo for allegedly lying to Congress about his decisions made during the COVID-19 pandemic while serving as governor, a source familiar with the probe confirmed to Fox News.

The New York Times first reported that the U.S. attorney’s office in Washington opened the inquiry into Cuomo about a month ago after senior officials in the DOJ demanded an indictment of New York City Mayor Eric Adams for corruption charges be dismissed.

Cuomo is running in the Democratic primary to serve as the next mayor of New York City, while Adams is seeking re-election as an independent candidate.

“We have never been informed of any such matter, so why would someone leak it now? The answer is obvious: This is lawfare and election interference plain and simple—something President Trump and his top Department of Justice officials say they are against,” Rich Azzopardi, Cuomo’s spokesperson told Fox News. “Governor Cuomo testified truthfully to the best of his recollection about events from four years earlier, and he offered to address any follow-up questions from the Subcommittee — but from the beginning this was all transparently political.”

Last year, Republican lawmakers questioned Cuomo about his handling of the COVID-19 pandemic. House Republicans subsequently recommended the Justice Department pursue criminal charges against him. They accused him of intentionally lying to Congress during the House Oversight Committee’s investigation into the excessive number of nursing home deaths.

House Oversight and Government Reform Committee Chair James Comer (R-Ky.) referred Cuomo to President Donald Trump’s Justice Department for criminal prosecution. 

Cuomo, who was governor at the time, issued a March 2020 directive that initially barred nursing homes from refusing to accept patients who had tested positive for COVID-19. The directive was aimed at freeing up beds for overwhelmed hospitals. 

More than 9,000 recovering coronavirus patients were released from hospitals into nursing homes under the directive, which was later rescinded amid speculation that it had accelerated outbreaks. Cuomo has previously said that the directive was based on the Centers for Disease Control and Prevention (CDC) and Centers for Medicare and Medicaid Services (CMS) guidance at the time.

A report released in March 2022 by the New York state comptroller found Cuomo’s Health Department “was not transparent in its reporting of COVID-19 deaths in nursing homes” and it “understated the number of deaths at nursing homes by as much as 50%” during some points of the pandemic. 

In a letter to Attorney General Pam Bondi last month, Comer said, “to our knowledge, the Biden Administration ignored this referral despite clear facts and evidence.” He requested that Bondi review the referral and “take appropriate action.” 

“Andrew Cuomo is a man with a history of corruption and deceit, now caught red-handed lying to Congress during the Select Subcommittee’s investigation into the COVID-19 nursing home tragedy in New York,” Comer said in a statement Monday. “This wasn’t a slip-up – it was a calculated cover-up by a man seeking to shield himself from responsibility for the devastating loss of life in New York’s nursing homes. Let’s be clear: lying to Congress is a federal crime. Mr. Cuomo must be prosecuted to the fullest extent of the law. The House Oversight Committee is prepared to fully cooperate with the Justice Department’s investigation into Andrew Cuomo’s actions and ensure he’s held to account.” 

Trump Names New Pick To Lead FDA

1
The White House, Public domain, via Wikimedia Commons

President Donald Trump has selected Dr. Heidi Overton, a senior White House domestic policy adviser and physician, to lead the Food and Drug Administration as the agency confronts battles over vaccines, drug prices, food additives, and abortion medication.

Trump announced the nomination Wednesday, describing Overton as a trusted problem-solver who would accelerate medical innovation, lower prescription costs, and advance Health and Human Services Secretary Robert F. Kennedy Jr.’s “Make America Healthy Again” agenda.

Overton currently serves as deputy director of the White House Domestic Policy Council, where she has helped formulate and promote several of the administration’s most consequential health initiatives.

If confirmed by the Senate, she would succeed Dr. Marty Makary, who left the agency in May after a turbulent tenure marked by internal disputes and disagreements over the direction of federal health policy.

Kyle Diamantas, who previously led the FDA’s Human Foods Program, is serving as acting commissioner.

A Physician With Deep White House Ties

Overton is a board-certified physician in public health and general preventive medicine. She earned her medical degree from the University of New Mexico School of Medicine and a doctorate in clinical investigation from the Johns Hopkins Bloomberg School of Public Health.

She previously trained as a general surgery resident at Johns Hopkins and advocated for greater price and quality transparency in health care.

During medical school, then-New Mexico Gov. Susana Martinez appointed Overton to the University of New Mexico Board of Regents, where she held voting and fiduciary responsibility for the university and its health system.

Overton first entered the Trump White House as a fellow in 2019, working in the Office of American Innovation and on the Domestic Policy Council. Between Trump’s terms, she served as chief policy officer at the America First Policy Institute and helped lead its Center for a Healthy America.

Her biography from the conservative organization emphasizes her work on health-care transparency, fentanyl, public health and policies designed to give patients greater control over medical decisions.

The appointment would place a committed administration loyalist at the head of an agency that regulates products representing roughly one-fifth of American consumer spending.

Overton Helped Shape Trump’s Health Agenda

Overton has appeared alongside Trump during major health policy announcements, including the administration’s efforts to negotiate “most favored nation” agreements with drug companies. The policy seeks to tie American prescription prices to the lower prices paid in other developed countries.

She was also involved in Trump’s controversial effort to revise the childhood vaccination schedule and separate the combined measles, mumps and rubella vaccine into three individual shots.

Major medical organizations have generally supported the combined MMR vaccine, which has been used for decades and reduces the number of clinical visits and injections required for full immunization. Critics fear that splitting the vaccine could create delays and lower vaccination rates.

Overton’s role in the policy is likely to become a focus of her Senate confirmation hearing, particularly as lawmakers question how she would handle pressure from Kennedy and other administration figures skeptical of established federal vaccine recommendations.

Trump praised Overton as a “rockstar” who would advance medical cures, innovation and lower drug prices.

Kennedy also supports the nomination, giving Overton an important ally inside the Department of Health and Human Services, which oversees the FDA.

Difficult Issues Await New Commissioner

The next FDA commissioner will inherit an unusually difficult collection of unfinished projects.

The agency continues to face pressure over its regulation of COVID-19 vaccines and other immunizations, including questions about which populations should receive updated shots and what evidence manufacturers must provide.

Medication abortion will present another immediate test. Pro-life organizations want the FDA to impose tighter restrictions on mifepristone, including limits on prescriptions issued through telehealth and pills delivered through the mail.

Overton has previously used the term “teleabortion” when discussing remote access to abortion medication, drawing concern from abortion-rights organizations that expect her to revisit the drug’s rules.

The FDA must also determine how aggressively it will regulate ultraprocessed foods, chemical additives, and synthetic dyes. Those issues are central to Kennedy’s MAHA movement but can conflict with the deregulatory approach traditionally favored by Republican lawmakers and industry groups.

Other pending questions involve flavored electronic cigarettes, peptide treatments, psychedelics, antidepressant warnings, and efforts to shorten the approval process for new drugs.

Overton would therefore have to balance three competing forces: Trump’s desire for faster approvals and lower prices, Kennedy’s campaign against corporate influence in food and medicine, and Republican demands for reduced federal regulation.

Management Experience Likely to Draw Scrutiny

Overton’s supporters point to her medical education, policy background, and proximity to presidential decision-making. They argue that she understands Trump’s priorities and can coordinate more effectively with the White House than an outside nominee.

Critics are expected to focus on her limited experience running an organization comparable to the FDA.

The agency employs thousands of scientists, physicians, inspectors, lawyers, and regulatory specialists. It oversees prescription drugs, medical devices, vaccines, tobacco products, much of the nation’s food supply, and other consumer goods.

Axios reported before her selection that some health policy observers worried Overton’s nomination could unsettle FDA career employees and pharmaceutical investors, while other potential candidates possessed more direct executive management experience.

The criticism will likely feature prominently when she appears before the Senate Health, Education, Labor and Pensions Committee.

Makary, Overton’s predecessor and a former Johns Hopkins colleague, was confirmed in March 2025 by a 56-44 Senate vote. Overton will seek confirmation from a chamber still controlled by Republicans but divided over the administration’s vaccine policies.

Her nomination signals that Trump wants the FDA led by someone already embedded in his White House rather than an agency insider or pharmaceutical executive.

If the Senate agrees, Overton will take control of one of the federal government’s most powerful scientific agencies — and become responsible for turning the administration’s sprawling health agenda into enforceable policy.